We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$478M
AUM Growth
-$27.4M
(-5.4%)
Cap. Flow
-$37.3M
Cap. Flow
% of AUM
-7.8%
Top 10 Holdings %
Top 10 Hldgs %
29.76%
Holding
113
New
12
Increased
22
Reduced
49
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$7.58M |
| 2 |
MBLY
Mobileye N.V.
MBLY
|
+$4.9M |
| 3 |
Ambarella
AMBA
|
+$4.73M |
| 4 |
Bright Horizons
BFAM
|
+$4.27M |
| 5 |
Tractor Supply
TSCO
|
+$3.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$14.5M |
| 2 |
Atmos Energy
ATO
|
+$5.49M |
| 3 |
Chubb
CB
|
+$4.86M |
| 4 |
Allstate
ALL
|
+$4.51M |
| 5 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$4.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.56% |
| 2 | Technology | 21.78% |
| 3 | Consumer Discretionary | 18.9% |
| 4 | Industrials | 8.09% |
| 5 | Financials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Abbott
ABT
$176B
| $240K | 0.05% |
+4,890
| New | +$235K |
|
|
EXAS
102
DELISTED
Exact Sciences
EXAS
| $237K | 0.05% |
8,000
-87,400
| -92% | -$2.2M |
|
103
US Bancorp
USB
$98.4B
| $226K | 0.05% |
5,209
| – | – |
|
|
NBSE
104
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $32K | 0.01% |
33
-370
| -92% | -$399K |
|
105
American Airlines Group
AAL
$8.99B
| – | – |
-55,000
| Closed | -$2.9M |
|
106
Applied Materials
AMAT
$444B
| – | – |
-143,000
| Closed | -$3.23M |
|
|
107
Chubb
CB
$136B
| – | – |
-43,600
| Closed | -$4.86M |
|
108
Canadian National Railway
CNI
$79.3B
| – | – |
-43,800
| Closed | -$2.93M |
|
109
Microsoft
MSFT
$2.83T
| – | – |
-7,800
| Closed | -$317K |
|
110
United Parcel Service
UPS
$97.1B
| – | – |
-19,900
| Closed | -$1.93M |
|
|
AGN
111
DELISTED
Allergan plc
AGN
| – | – |
-48,585
| Closed | -$14.5M |
|
|
SLXP
112
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| – | – |
-3,100
| Closed | -$535K |
|
|
GCVRZ
113
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| – | – |
-39,800
| Closed | -$26K |
|
Similar funds
ECA
DWML
BOA
PLU
CPW
CAAM
SCP
EFMC
De Burlo Group's Q2 2015 Portfolio in Review
As of Q2 2015, De Burlo Group held 113 positions worth $478M, down 5.4% from $505M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
De Burlo Group withdrew a net $37.3M in Q2 2015, closing 9 positions and reducing 49 holdings. Its most notable exit was Allergan plc, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, De Burlo Group opened a new position in Palo Alto Networks worth $8.26M.
- De Burlo Group's largest Q2 2015 buy was Palo Alto Networks: 283,800 shares worth $8.26M.
- De Burlo Group added most to Perrigo in Q2 2015, an estimated $3.28M increase.
- De Burlo Group's biggest Q2 2015 reduction was Atmos Energy, cutting an estimated $5.49M.
- De Burlo Group fully exited Allergan plc in Q2 2015, selling an estimated $14.5M.
- De Burlo Group's ten largest holdings make up 30% of its $478M portfolio in Q2 2015.
- De Burlo Group opened 12 new positions and closed 9 in Q2 2015.
- De Burlo Group's portfolio value fell 5.4% quarter-over-quarter to $478M.
Based on De Burlo Group's 13F filing for Q2 2015, filed 7 Aug 2015.